Back to search

Sweden· SE-20100805000107

Trajenta 5 mg Filmdragerad tablett

A medicinal product containing linagliptin, registered in Sweden by Boehringer Ingelheim International GmbH.

Checked against Swedish Medical Products Agency (Sweden) on

Informational only — not a medical device.

SOURCE REGISTER · SESwedish Medical Products Agency (Sweden)normalisedTrajenta 5 mg Filmdragerad tablettATC—REGISTER NO.SE-20100805000107PACKS LISTED1CHECKEDOctober 1, 2026

The record

At a glance

Swedish Medical Products Agency (Sweden)
Active substance
Linagliptin
Manufacturer
Boehringer Ingelheim International GmbH
Country
Sweden (SE)
ATC code
—
Reimbursed
Not published by this register
Source register
Swedish Medical Products Agency (Sweden)
Last checked
October 1, 2026

Packs & prices · 1

  • se_varunummer
    20100805000107

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Linagliptin in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All linagliptin products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Ilinpru, Liamell
  • Belgium · Linagliptin Eg, Linagliptin Eg (Eurogenerics) Nv
  • Bulgaria · Linagliptin Accord, Глунава
  • Cyprus · Glunava, Linagliptin Accord
  • Czechia · Glunava, Jeligo
  • Germany · Linagliptin Abdi
  • Denmark · Linagliptin "pharmapath", Linagliptin Accord
  • Estonia · Glunava, Linagliptin Accord
  • Spain · Donumid, Ilinpru
  • Finland · Linagliptin Accord, Linagliptin Advanz Pharma
  • France · Linagliptine Zentiva
  • United Kingdom (Northern Ireland) · Linagliptin, Linagliptin Altair Science
  • Greece · Bottiar, Drojarto
  • Croatia · Larida, Liglinra
  • Hungary · Ilinpru, Jeligo
  • Ireland · Linagliptin Accord, Linagliptin Clonmel
  • Iceland · Linagliptin Krka, Linagliptin Stada
  • Italy · Linagliptin Abdi, Linagliptin Aurobindo
  • Liechtenstein · Trajenta
  • Lithuania · Bottiar, Jeligo
  • Luxembourg · Linagliptin Eg
  • Latvia · Linagliptin Accord, Linagliptin Olpha
  • Malta · Liamell, Linagliptin
  • Netherlands · Linagliptin Viatris, Linagliptin Vivanta
  • Norway · Linagliptin Accord, Linagliptin Krka
  • Poland · Jeligo, Larida
  • Portugal · Enanta, Larida
  • Romania · Jeligo, Linagliptin Medochemie
  • Slovenia · Liglipex, Linagliptin Krka
  • Slovakia · Glunava, Ilinpru

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ce1948e8-54c1-4195-a574-66307dbdece9
GET /v1/drugs/ce1948e8-54c1-4195-a574-66307dbdece9?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "lakemedelsverket",
  "doc_types": [
    "EMA",
    "EPAR"
  ],
  "se_npl_id": "20100805000107",
  "product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20100805000107",
  "product_doc_link": "https://www.ema.europa.eu/en/medicines/human/EPAR/trajenta"
}

See everything about linagliptin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.